Country: United States
Language: English
Source: NLM (National Library of Medicine)
HUMAN IMMUNOGLOBULIN G (UNII: 66Y330CJHS) (HUMAN IMMUNOGLOBULIN G - UNII:66Y330CJHS)
Bio Products Laboratory Limited
HUMAN IMMUNOGLOBULIN G
HUMAN IMMUNOGLOBULIN G 5 g in 50 mL
INTRAVENOUS
GAMMAPLEX 10% is an Immune Globulin Intravenous (Human), 10% Liquid indicated for replacement therapy in primary humoral immunodeficiency (PI) in adults and pediatric patients 2 years of age and older. This includes, but is not limited to, the humoral immune defect in common variable immunodeficiency, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies. GAMMAPLEX 10% is indicated for the treatment of chronic immune thrombocytopenic purpura (ITP) in adults to raise platelet counts. - GAMMAPLEX 10% is contraindicated in patients who have had an anaphylactic or severe systemic reaction to the administration of human immune globulin - GAMMAPLEX 10% is contraindicated in IgA-deficient patients with antibodies to IgA and a history of hypersensitivity Risk Summary Animal reproduction studies have not been conducted with GAMMAPLEX 10%. It is also not known whether GAMMAPLEX 10% can cause fetal harm when administered to a pregnant woman or can af
GAMMAPLEX 10% is supplied in a single use, clear Type II glass bottle, closed with a stopper and oversealed with a tamper-evident cap. The components used in the packaging for GAMMAPLEX 10% are not made with natural rubber latex. The following presentations of GAMMAPLEX 10% are available: Each vial has a label with a peel-off strip showing the product name and batch number. When stored between 2°C [35.6°F] and 25°C [77°F]), GAMMAPLEX 10% has a shelf life of 36 months. Keep GAMMAPLEX 10% in its original carton to protect it from light. Do not shake. Do not use GAMMAPLEX 10% beyond the expiration date on the product label. Do not freeze.
Biologic Licensing Application
GAMMAPLEX- HUMAN IMMUNOGLOBULIN G SOLUTION BIO PRODUCTS LABORATORY LIMITED ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE GAMMAPLEX 10% SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR GAMMAPLEX 10%. GAMMAPLEX 10% IMMUNE GLOBULIN INTRAVENOUS [HUMAN], 10% LIQUID INITIAL U.S. APPROVAL: 2017 WARNING: THROMBOSIS, RENAL DYSFUNCTION AND ACUTE RENAL FAILURE _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING._ THROMBOSIS MAY OCCUR WITH IMMUNE GLOBULIN PRODUCTS, INCLUDING GAMMAPLEX 10%. RISK FACTORS MAY INCLUDE: ADVANCED AGE, PROLONGED IMMOBILIZATION, HYPERCOAGULABLE CONDITIONS, HISTORY OF VENOUS OR ARTERIAL THROMBOSIS, USE OF ESTROGENS, INDWELLING VASCULAR CATHETERS, HYPERVISCOSITY AND CARDIOVASCULAR RISK FACTORS (5.2) RENAL DYSFUNCTION, ACUTE RENAL FAILURE, OSMOTIC NEPHROSIS, AND DEATH MAY OCCUR IN PREDISPOSED PATIENTS WITH IMMUNE GLOBULIN INTRAVENOUS (LGIV) PRODUCTS, INCLUDING GAMMAPLEX 10% RENAL DYSFUNCTION AND ACUTE RENAL FAILURE OCCUR MORE COMMONLY WITH IGIV PRODUCTS CONTAINING SUCROSE. GAMMAPLEX 10% DOES NOT CONTAIN SUCROSE (5.1) FOR PATIENTS AT RISK OF THROMBOSIS, RENAL DYSFUNCTION OR ACUTE RENAL FAILURE, ADMINISTER GAMMAPLEX 10% AT THE MINIMUM DOSE AND INFUSION RATE PRACTICABLE. ENSURE ADEQUATE HYDRATION IN PATIENTS BEFORE ADMINISTRATION. MONITOR FOR SIGNS AND SYMPTOMS OF THROMBOSIS AND ASSESS BLOOD VISCOSITY IN PATIENTS AT RISK FOR HYPERVISCOSITY (2.3, 5.2) INDICATIONS AND USAGE GAMMAPLEX 10% is an Immune Globulin Intravenous (Human) 10% Liquid indicated for the treatment of: primary humoral immunodeficiency (PI) in adults and pediatric patients 2 years of age and older (1.1) chronic immune thrombocytopenic purpura (ITP) in adults (1.2) DOSAGE AND ADMINISTRATION FOR INTRAVENOUS USE ONLY INDICATION DOSE INITIAL INFUSION RATE MAINTENANCE INFUSION RATE (IF TOLERATED) PI 300-800 mg/kg (3-8 mL/kg) every 3-4 weeks 0.5 mg/kg/min (0.005 mL/kg/min) for 15 minutes Increase gradually every 15 minutes to 8 mg/kg/min (0.08 mL/kg/min) IT Read the complete document